SEC Form 4 · accession 0001053369-15-000006
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeenarine Narine
Director · 10% Owner
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 3:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common | Mar 5, 2015 | A | 58,475 | $0.342 | A | 5,568,930 | D | |
| commonF1 | holding | — | — | — | 14,887,229 | I | by Epic Investments, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Jeenarine Narine is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer, and also serves as a director of the issuer.